Covaxin
Covaxin is India's indigenous COVID-19 vaccine, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
This indigenous, inactivated vaccine is produced within Bharat Biotech's high containment facility classified as BSL-3 (Bio-Safety Level 3).
Covaxin is designed using the Whole-Virion Inactivated Vero Cell platform technology. Inactivated vaccines do not replicate, minimizing the risk of reversion and associated pathological effects. They consist of deactivated viruses, incapable of causing infection while still instructing the immune system to generate a protective response against the infection.
Indication and Usage –
Dosage and Administration –
Contraindications –
Adverse reactions –
Side effects that have been reported with Covaxin include:
A severe allergic reaction may very rarely occur after getting a dose of Covaxin.
These may not be all the possible side effects of Covaxin.
Drug interactions and other interactions –
Frequently asked questions and their answers:
1. What is Covaxin and what is it used for?
Covaxin is a vaccine designed for active immunization against SARS-CoV-2 virus infection.
2. Key considerations before receiving Covaxin?
Before receiving Covaxin, you should inform the vaccination provider of all your medical conditions, including:
3. What is contained in Covaxin?
The ingredients in Covaxin include:
COVAXIN has been developed using an inactivated/killed virus in combination with the above-mentioned chemicals.
4. How is Covaxin administered?
Covaxin is administered via an injection into the deltoid muscle of the upper arm. The vaccination series consists of two doses given four weeks apart.
Your email address will not be published. Required fields are marked *